Which cervical and endometrial cancer patients will benefit most from intensity-modulated proton therapy?

Which cervical and endometrial cancer patients will benefit most from intensity-modulated proton therapy?
Radiother Oncol. 2016 Jul 21;
Authors: van de Sande MA, Creutzberg CL, van de Water S, Sharfo AW, Hoogeman MS
Abstract
In this dosimetric comparison study it was shown that IMPT with robust planning reduces dose to surrounding organs in cervical and endometrial cancer treatment compared with IMRT. Especially for the para-aortic region, clinically relevant dose reductions were obtained for kidneys, spinal cord and bowel, justifying the use of proton therapy for this indication.
PMID: 27452411 [PubMed - as supplied by publisher]

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - July 20, 2016 Category: Radiology Authors: van de Sande MA, Creutzberg CL, van de Water S, Sharfo AW, Hoogeman MS Tags: Radiother Oncol Source Type: research